QOP
ISEE

Quinn Opportunity Partners’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Quinn Opportunity Partners’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-36,000
Closed -$99K – 218
2018
Q1 		$99K Hold
36,000
– – 0.01% 191
2017
Q4 		$112K Sell
36,000
-29,000
-45% -$81.5K 0.02% 169
2017
Q3 		$183K Buy
65,000
+24,000
+59% +$64.8K 0.03% 197
2017
Q2 		$105K Sell
41,000
-72,973
-64% -$199K 0.02% 159
2017
Q1 		$417K Sell
113,973
-139,897
-55% -$591K 0.1% 118
2016
Q4 		$1.23M Buy
253,870
+233,370
+1,138% +$6.93M 0.37% 69
2016
Q3 		$946K Buy
+20,500
New +$1.16M 0.34% 62

Other funds holding ISEE

D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Quinn Opportunity Partners's ISEE Position: Q2 2018 in Review

Quinn Opportunity Partners sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2018, closing a stake of 36,000 shares — an estimated $99K sold.

Quinn Opportunity Partners first reported a position in ISEE in Q3 2016 and held it in 7 quarters. The position peaked at $1.23M in Q4 2016. 73 funds tracked by Wall St. Rank hold ISEE as of Q2 2018.

  • Quinn Opportunity Partners reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Quinn Opportunity Partners sold 36,000 IVERIC bio, Inc. Common Stock shares in Q2 2018, an estimated $99K.
  • Quinn Opportunity Partners first reported a position in IVERIC bio, Inc. Common Stock in Q3 2016 and held it in 7 quarters.
  • Quinn Opportunity Partners's IVERIC bio, Inc. Common Stock position peaked at $1.23M in Q4 2016.
  • 73 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2018.

Based on Quinn Opportunity Partners's 13F filing for Q2 2018, filed 14 Aug 2018.